Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957

Watchlist Manager
Yunnan Botanee Bio-Technology Group Co Ltd Logo
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Watchlist
Price: 47.9 CNY -5.41% Market Closed
Market Cap: 20.1B CNY
Have any thoughts about
Yunnan Botanee Bio-Technology Group Co Ltd?
Write Note

Net Margin
Yunnan Botanee Bio-Technology Group Co Ltd

13.3%
Current
19%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.3%
=
Net Income
790.6m
/
Revenue
6B

Net Margin Across Competitors

Country CN
Market Cap 20.1B CNY
Net Margin
13%
Country FR
Market Cap 176B EUR
Net Margin
15%
Country UK
Market Cap 117.3B GBP
Net Margin
11%
Country IN
Market Cap 5.7T INR
Net Margin
17%
Country UK
Market Cap 34.7B GBP
Net Margin
11%
Country DE
Market Cap 27.7B EUR
Net Margin
8%
Country US
Market Cap 25.1B USD
Net Margin
1%
Country JP
Market Cap 2.9T JPY
Net Margin
5%
Country IN
Market Cap 1.2T INR
Net Margin
-3%
Country IN
Market Cap 909.1B INR
Net Margin
14%
Country US
Market Cap 10.2B USD
Net Margin
12%
No Stocks Found

Yunnan Botanee Bio-Technology Group Co Ltd
Glance View

Market Cap
20.1B CNY
Industry
Consumer products

Yunnan Botanee Bio-Technology Group Co., Ltd. engages in the research and development, manufacture, and sales of skin care products and services. The company is headquartered in Kunming, Yunnan and currently employs 2,378 full-time employees. The company went IPO on 2021-03-25. The firm adopts a sales model based on offline channel sales and online channel sales as the leading factor. The firm's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The firm is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.

Intrinsic Value
68.83 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.3%
=
Net Income
790.6m
/
Revenue
6B
What is the Net Margin of Yunnan Botanee Bio-Technology Group Co Ltd?

Based on Yunnan Botanee Bio-Technology Group Co Ltd's most recent financial statements, the company has Net Margin of 13.3%.